浏览全部资源
扫码关注微信
1.国家卫生健康委医院管理研究所药事管理研究部,北京 100044
2.上海市老年医学中心药学部,上海 201104
3.复旦大学附属中山医院药学部,上海 200032
Published:30 September 2024,
Received:13 March 2024,
Revised:28 August 2024,
移动端阅览
吕红梅,赵婧,府裕琦等.我国静脉用药调配中心调配种类及工作量现状调研分析 Δ[J].中国药房,2024,35(18):2203-2206.
LYU Hongmei,ZHAO Jing,FU Yuqi,et al.Research and analysis of the blending types and workload of PIVAS in China[J].ZHONGGUO YAOFANG,2024,35(18):2203-2206.
吕红梅,赵婧,府裕琦等.我国静脉用药调配中心调配种类及工作量现状调研分析 Δ[J].中国药房,2024,35(18):2203-2206. DOI: 10.6039/j.issn.1001-0408.2024.18.03.
LYU Hongmei,ZHAO Jing,FU Yuqi,et al.Research and analysis of the blending types and workload of PIVAS in China[J].ZHONGGUO YAOFANG,2024,35(18):2203-2206. DOI: 10.6039/j.issn.1001-0408.2024.18.03.
目的
2
评估我国静脉用药调配中心(PIVAS)的调配种类及工作量现状。
方法
2
通过问卷调查方式,调研全国范围内不同级别医院PIVAS工作情况,调研内容包括调配液体种类,危害药品输液、肠外营养液、普通药物及抗菌药物输液、静脉推注药物、皮试液、注射剂的每日调配量及每日打包量。
结果
2
纳入全国30个省(区、市)的750个PIVAS,涉及三级医院621家、二级医院90家;调配液体种类以静脉输液为主,其次为肠外营养液,再次为化疗泵(含化疗输液),分别占99.73%、79.47%、43.33%。三级医院PIVAS的危害药品输液、肠外营养液、普通药物输液、抗菌药物输液、静脉推注药物、皮试液、注射剂的每日调配量分别为23.00(9.00,56.50)组、31.00(13.97,74.00)袋、813.00(375.00,2 061.75)袋、426.00(210.00,987.00)袋、30.00(6.00,155.00)支、30.00(7.13,136.84)支、3 200.00(1 684.50,5 554.50),每日打包量为218.50(52.26,559.00)袋;二级医院PIVAS的上述指标分别为4.00(2.00,12.00)组、8.90(3.00,23.00)袋、270.50(108.00,2 061.75)袋、157.00(71.00,987.00)袋、5.85(3.75,141.00)支、0支、1 349.00(548.10, 2 408.00)支、107.50(33.25,207.00)袋。
结论
2
PIVAS的调配种类范围已明显扩大;三级医院在各类静脉输液和药物的调配量及打包量上均明显高于二级医院,其在处理复杂药物和高风险治疗药物方面具有明显优势。
OBJECTIVE
2
To assess the blending types and workload of pharmacy intravenous admixture services (PIVAS) in China.
METHODS
2
By questionnaire survey, the working status of PIVAS in different levels of hospitals nationwide was investigated, involving the types of blending infusion, daily blending volume of hazardous drugs infusion, parenteral nutrition solution, general and antibacterial drug infusion, intravenous bolus drugs, skin test solution and intravenous agents, as well as the daily packing volume.
RESULTS
2
A sample of 750 PIVAS in 30 provinces (autonomous regions, municipalities) across China were surveyed by questionnaire, involving 621 tertiary hospitals and 90 secondary hospitals. The main types of liquid preparation were intravenous infusion, followed by parenteral nutrition solution, and chemotherapy pump (including chemotherapy infusion), accounting for 99.73%, 79.47% and 43.33%, respectively. The daily blending volume of hazardous drugs infusion, parenteral nutrition solution, general and antibacterial drug infusion, intravenous bolus drugs, skin test solution and intravenous agents in PIVAS of tertiary hospitals were 23.00 (9.00, 56.50) sets, 31.00 (13.97, 74.00) bags, 813.00 (375.00, 2 061.75) bags, 426.00 (210.00, 987.00) bags, 30.00 (6.00, 155.00) ampoules, 30.00 (7.13, 136.84) ampoules, 3 200.00 (1 684.50, 5 554.50) ampoules respectively, while the daily packing volume was 218.50 (52.26, 559.00) bags; above indexes of PIVAS in secondary hospital were 4.00(2.00,12.00)sets, 8.90(3.00,23.00)bags, 270.50(108.00, 2 061.75)bags, 157.00(71.00,987.00)bags, 5.85(3.75,141.00) ampoules, 0 ampoule, 1 349.00(548.10,2 408.00)ampoules, 107.50(33.25,207.00)bags.
CONCLUSIONS
2
The scope of blending types of PIVAS has been significantly expanded, and tertiary hospitals are significantly higher than secondary hospitals in the blending and packing volumes of all types of intravenous fluids and drugs dispensed, showing obvious advantages in dealing with complex medications and high-risk treatments.
静脉用药调配中心调配种类调配量打包量
blending typesblending volumepacking volume
卫生部.医疗机构药事管理规定[EB/OL].(2011-01-30)[2023-12-20].http://www.nhc.gov.cn/wjw/gfxwj/201304/0149ba1f66bd483995bb0ea51a354de1.shtmlhttp://www.nhc.gov.cn/wjw/gfxwj/201304/0149ba1f66bd483995bb0ea51a354de1.shtml.
Ministry of Health. Regulations on pharmaceutical admi-nistration in medical institutions[EB/OL].(2011-01-30)[2023-12-20]. http://www.nhc.gov.cn/wjw/gfxwj/201304/0149ba1f66bd483995bb0ea51a354de1.shtmlhttp://www.nhc.gov.cn/wjw/gfxwj/201304/0149ba1f66bd483995bb0ea51a354de1.shtml.
赵越,董占军. 静脉用药调配中心整体规划及三个功能区的设置:《静脉用药调配中心建设与管理指南》系列解读:二[J]. 中国医院药学杂志,2022,42(19):1974-1977.
ZHAO Y,DONG Z J. Overall plan of PIVAS and setting of three functional areas:series articles of interpreting guidelines for the Establishment and Management of Pharmacy Intravenous Admixture Services:Ⅱ[J]. Chin J Hosp Pharm,2022,42(19):1974-1977.
张峻,吴迪,吴永佩. 加强监督与技术指导,促进PIVAS规范化建设:《静脉用药调配中心建设与管理指南》系列解读:一[J]. 中国医院药学杂志,2022,42(19):1969-1973.
ZHANG J,WU D,WU Y P. Enhancing supervision and technical instruction to promote the establishment of standardized PIVAS:series articles of interpreting guidelines for the Establishment and Management of Pharmacy Intravenous Admixture Services:Ⅰ[J]. Chin J Hosp Pharm,2022,42(19):1969-1973.
国家卫生健康委办公厅. 静脉用药调配中心建设与管理指南:试行[EB/OL].(2021-12-10)[2023-12-20].http://www.gov.cn/zhengce/zhengceku/2021-12/21/content_5663666.htmhttp://www.gov.cn/zhengce/zhengceku/2021-12/21/content_5663666.htm.
General Office of National Health Commission. Guidelines for the construction and management of intravenous medication dispensing centers:trial[EB/OL].(2021-12-10)[2023-12-20].http://www.gov.cn/zhengce/zhengceku/2021-12/21/content_5663666.htmhttp://www.gov.cn/zhengce/zhengceku/2021-12/21/content_5663666.htm.
国家卫生计生委.静脉用药集中调配质量管理规范[EB/OL].(2010-04-20)[2023-12-20]. http://www.nhc.gov.cn/bgt/s10787/201004/09f4230d6bce4f53a857979112850482.shtmlhttp://www.nhc.gov.cn/bgt/s10787/201004/09f4230d6bce4f53a857979112850482.shtml.
National Health and Family Planning Commission. Norms for quality management of centralized dispensing of intravenous drugs [EB/OL].(2010-04-20)[2023-12-20]. http://www.nhc.gov.cn/bgt/s10787/201004/09f4230d6bce4f53a-857979112850482.shtmlhttp://www.nhc.gov.cn/bgt/s10787/201004/09f4230d6bce4f53a-857979112850482.shtml.
蔡明远,张翠莲,周亮,等. 全国医疗机构制剂现状调研及问题分析[J]. 中国药房,2022,33(5):513-518.
CAI M Y,ZHANG C L,ZHOU L,et al. Nationwide investigation and problems analysis of pharmaceutical preparations in medical institutions[J]. China Pharm,2022,33(5):513-518.
庞国勋,王涛,靳会欣. 我国静脉用药集中调配中心可持续发展的关键要素分析[J]. 中国药房,2020,31(23):2901-2908.
PANG G X,WANG T,JIN H X. Key elements analysis of sustainable development of pharmacy intravenous admixture services in China[J]. China Pharm,2020,31(23):2901-2908.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution